In terms of the pattern of COVID-19 presentation, most patients (484 [61%]) presented with fever, cough (377 [47%]), or shortness of breath (312 [39%]). However, diarrhoea (51 [6%]), nausea and vomiting (39 [5%]), ageusia (13 [2%]), and anosmia (nine [1%]) were also identified as presenting symptoms. A mild COVID-19 severity category was recorded in 412 (52%) patients, with 96 (12%) patients not requiring hospital admission. 315 (39%) patients required oxygen, and 53 (7%) patients received intensive therapy unit (ITU) level care. Of these 53 patients, six (11%) were discharged, 23 (43%) died and 24 (45%) were either still in ITU or did not have a final recorded outcome. 226 (28%) patients died, with reports stating that the death was principally attributable to COVID-19 in most patients (211 [93%]). Compared with the rest of the cancer cohort, patients who died were significantly older (median 73·0 years vs 66·0 years; p<0·001), , more were male (146 [33%] of 449) than female (80 [20%] of 349), and those who died also displayed higher rates of comorbidities compared with those who did not, including cardiovascular disease (21% vs 11%; p<0·001) and hypertension (41% vs 27%; p<0·001. Patients who died were also more likely to present with symptoms of shortness of breath (57% vs 32%; p<0·001).